Alcoholic Cardiomyopathy Management and Pathophysiology

Pathophysiology and Mechanisms

Alcohol causes direct toxic damage to myocardial cells, leading to progressive ventricular dysfunction and dilated cardiomyopathy, as stated by the American Heart Association 1

The American College of Cardiology notes that alcoholic cardiomyopathy typically develops in patients consuming more than 90 grams of alcohol daily for more than 5 years, although this fact is not directly cited, men aged 30-55 years who have been heavy drinkers for more than 10 years are at higher risk 2, 3
Women are more vulnerable to alcoholic cardiomyopathy, developing the condition with lower total lifetime alcohol exposure than men, and experiencing higher mortality risk, according to the American Heart Association 2, 3
Individual susceptibility to alcoholic cardiomyopathy relates to mean daily alcohol intake, duration of drinking, and genetic predisposition, as reported by the European Society of Cardiology 4, 2

Left ventricular hypertrophy and remodeling occur as early responses to heavy drinking, and diastolic dysfunction develops in approximately one-third of alcoholics, correlating with consumption levels, as stated by the American College of Cardiology 5
Dilated cardiomyopathy develops in 20-26% of heavy drinkers within 5 years, according to the European Society of Cardiology 5, 6

Total abstinence from alcohol combined with standard heart failure therapy is the cornerstone of treatment, improving mortality, as recommended by the American Heart Association 1
Complete abstinence is mandatory and represents the most critical intervention for reversing myocardial damage, with numerous reports documenting improvement in depressed left ventricular function after cessation of drinking, as stated by the American College of Cardiology 1, 5, 6
The American Heart Association recommends applying guideline-directed medical therapy for heart failure with reduced ejection fraction, including ACE inhibitors or ARBs 3, beta-blockers 7, mineralocorticoid receptor antagonists 7, diuretics for volume management 2, and SGLT2 inhibitors (based on contemporary heart failure guidelines) 7
Thiamine supplementation is essential because chronic alcoholism predisposes to thiamine deficiency, which can cause or contribute to cardiomyopathy development, especially after declaring abstinence, as noted by the American College of Cardiology 1

For patients with ventricular arrhythmias, complete abstinence from alcohol is recommended when correlation exists between alcohol intake and ventricular arrhythmias, as stated by the European Society of Cardiology 5, 6
Persistent life-threatening ventricular arrhythmias despite abstinence should be treated with standard therapy including ICD placement in patients receiving optimal medical therapy with reasonable expectation of survival greater than 1 year, according to the American Heart Association 5, 6

Persistent biventricular dysfunction and chamber dilation occur in individuals with ongoing heavy alcohol exposure. 8

Long‑term heavy alcohol use (≥10 years) markedly raises the risk of developing cardiomyopathy in middle‑aged adults. 8

Acute alcohol ingestion reduces left‑ventricular ejection volume and myocardial contractility. 8

Low‑to‑moderate intake (approximately 1–2 standard drinks per day) is linked to a modest protective association with cardiovascular outcomes in observational cohorts, although this may reflect confounding lifestyle factors. (Observational evidence) 9
Heavy or binge drinking consistently correlates with increased cardiovascular morbidity and mortality. (Observational evidence) 9

In patients who continue drinking, mortality reaches 40–50 % within 3–6 years. 8
Overall survival is significantly lower for continuing drinkers compared with individuals who achieve complete abstinence or with patients who have idiopathic dilated cardiomyopathy. 8